APO-IBUPROFEN/CODEINE 200/12.8 film-coated tablet, blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-ibuprofen/codeine 200/12.8 film-coated tablet, blister pack

arrotex pharmaceuticals pty ltd - ibuprofen, quantity: 200 mg; codeine phosphate hemihydrate, quantity: 12.8 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; colloidal anhydrous silica; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 400 - for temporary relief of acute moderate pain and inflammation in patients over the age of 12 years (see also section contraindications and special warnings and precuations for use - paediatric use)

SANDOZ IBUPROFEN PLUS CODEINE film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz ibuprofen plus codeine film coated tablet blister pack

sandoz pty ltd - codeine phosphate hemihydrate, quantity: 12.8 mg; ibuprofen, quantity: 200 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - for the temporary relief of acute moderate pain and inflammation in patients over the age of 12 years (see also contraindications and paediatric use)

Ibuprofen Tablet, film coated 600mg Malta - English - Medicines Authority

ibuprofen tablet, film coated 600mg

accord healthcare limited - ibuprofen - film-coated tablet - ibuprofen 600 mg - antiinflammatory and antirheumatic products

Melfen 200mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

melfen 200mg film-coated tablets

clonmel healthcare ltd - ibuprofen ph. eur. - film-coated tablet - 200 milligram(s) - propionic acid derivatives; ibuprofen

Melfen 400mg Film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

melfen 400mg film-coated tablets

clonmel healthcare ltd - ibuprofen ph. eur. - film-coated tablet - 400 milligram(s) - propionic acid derivatives; ibuprofen

Non-Drowsy Sudapro Head Cold 200mg / 30mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

non-drowsy sudapro head cold 200mg / 30mg film-coated tablets

mcneil healthcare (ireland) ltd - ibuprofen; pseudoephedrine hydrochloride - film-coated tablet - 200/30 milligram(s) - other cold preparations

Non-Drowsy Sudapro Head Cold 200mg / 30mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

non-drowsy sudapro head cold 200mg / 30mg film-coated tablets

johnson & johnson (ireland) limited - ibuprofen; pseudoephedrine hydrochloride - film-coated tablet - 200 mg/30 milligram(s) - other cold preparations

Brupro Cold & Flu 200 mg/30 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

brupro cold & flu 200 mg/30 mg film-coated tablets

rowa pharmaceuticals limited - ibuprofen; pseudoephedrine hydrochloride - film-coated tablet - 200/30 milligram(s) - other cold preparations

IBUPROFEN/PSEUDOEPHEDRINE HYDROCHLORIDE 200/30 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

ibuprofen/pseudoephedrine hydrochloride 200/30 milligram film coated tablet

mcneil healthcare (ireland) ltd - ibuprofen, pseudoephedrine hydrochloride - film coated tablet - 200/30 milligram - other cold preparations

VORICONAZOLE SANDOZ voriconazole 50mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

voriconazole sandoz voriconazole 50mg film-coated tablet blister pack

sandoz pty ltd - voriconazole, quantity: 50 mg - tablet, film coated - excipient ingredients: povidone; croscarmellose sodium; lactose monohydrate; magnesium stearate; pregelatinised maize starch; titanium dioxide; hypromellose; triacetin - voriconazole sandoz is indicated for treatment of the following fungal infections:,- invasive aspergillosis.,- serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,- serious fungal infections caused by scedosporium spp and fusarium spp.,- other serious fungal infections, in patients intolerant of, or refractory to, other therapy,- prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.,- this brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets. for dosing requirements for populations who require intravenous or oral suspension treatment see dosage and administration.